View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
February 1, 2019

IQVIA introduces new capabilities for clinical trial communications

IQVIA, a life sciences technology solutions provider, has introduced two new capabilities to facilitate easy and fast sharing of cross-trial training materials and safety notifications between clinical teams.

Sponsors and contract research organisations can use the cross-trial functionality to communicate with sites across different studies, geographic locations and site roles.

Free Whitepaper
img

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

IQVIA said that the new features decrease site workload through distribution and tracking of necessary clinical trainings and safety notifications across all trials.

The capabilities are available via a dashboard that enables users to push and track trainings and safety notifications. They can be accessed by all IQVIA full-service clinical studies.

IQVIA Global Technology Solutions senior vice-president Tal Rosenberg said: “Our latest platform upgrades help ensure that sponsors, IQVIA, and other CROs can notify sites about safety events and trainings from one centralised dashboard, while removing duplicative activities that were previously inherent in the process. Simply put, this makes it easier for everyone.”

The company added that the new capabilities facilitate transparency in audit-trail documentation by automatic tracking of notification, acknowledgement.

In addition, the features are claimed to save cost and time, mitigate audit and legal liability, as well as help in automatic detection of noncompliant site personnel for training and safety acknowledgement.

Formed as a result of merger between IMS Health and Quintiles, IQVIA offers advanced analytics, technology solutions and contract research services for the life sciences industry.

The company uses human data science to facilitate enhancement of new clinical development and commercialisation techniques, and improve healthcare outcomes.

Related Companies

Free Whitepaper
img

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena